| Document and Entity Information | Mar. 06, 2022 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Mar. 6, 2022 |
| Entity Registrant Name | Brooklyn ImmunoTherapeutics, Inc. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-11460 |
| Entity Tax Identification Number | 31-1103425 |
| Entity Address, Address Line One | 140 58th Street, Building A |
| Entity Address, Address Line Two | Suite 2100 |
| Entity Address, City or Town | Brooklyn |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 11220 |
| City Area Code | 212 |
| Local Phone Number | 582-1199 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | false |
| Entity Central Index Key | 0000748592 |
| Title of 12(b) Security | Common Stock, par value $0.005 per share |
| Trading Symbol | BTX |
| Security Exchange Name | NASDAQ |
